[1]白侠,王雪梅.PET脑显像对致痫灶的定位方法[J].国际放射医学核医学杂志,2009,33(6):337-340.[doi:10.3760/cma.j.issn.1673-4114.2009.06.005]
 BAI Xia,WANG Xue-mei.The methods of PET cerebral imaging in focus localizing of epilepsy[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(6):337-340.[doi:10.3760/cma.j.issn.1673-4114.2009.06.005]
点击复制

PET脑显像对致痫灶的定位方法(/HTML)
分享到:

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第6期
页码:
337-340
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The methods of PET cerebral imaging in focus localizing of epilepsy
作者:
白侠 王雪梅
内蒙古医学院附属医院核医学科, 呼和浩特, 010050
Author(s):
BAI Xia WANG Xue-mei
Department of Nuclear Medicine, The Affiliated Hospital of Inner Mongolia Medical College, Huhhot 010050, China
关键词:
癫痫氟脱氧葡萄糖F18正电子发射断层显像术
Keywords:
EpilepsyFluorodeoxyglucoseF18Positron-emmission tomography
DOI:
10.3760/cma.j.issn.1673-4114.2009.06.005
摘要:
癫痫是一种极为复杂的综合性疾病,严重影响着患者的智力及日常生活。但是癫痫的治愈率却非常低,因为之一就是致痫灶的准确定位。临床上用于致痫灶定位的主要方法有:脑电图、磁共振成像、磁共振波谱扫描、脑磁图以及PET脑显像等。PET腩显像可以从脑组织代谢、血流灌注、生化、功能、氧耗、化学递质及神经受体等方面对致痫灶进行定位,提高了致痫灶的检出率,从而为癫痫患者的下一步治疗指明了方向。
Abstract:
Epilepsy is a very complicate and synthetic disease which influence patients intelligence and daily life acutely. But the cure rate of epilepsy is much low. One of the results is precise localization of disease which result in epilepsy. Today the main methods are electroencephalogram, magnetic resonance imaging, magnetic resonance spectroscopy and PET cerebral imaging. PET cerebral imaging can locate epileptic foci of epilepsy from the brain organization metabolism, blood, the bio-chemical, function and oxygen consume, the chemistry pass quality and nerve receptor. It raises the rate of checking the epileptic foci and indicates a direction for the next treatments of epilepsy.

参考文献/References:

[1] 吴湖炳,王全师,王明芳,等.18F-FDG PET显像对致痫灶的定位及在外科治疗中的价值.中华核医学杂志,2006,26(2):69-72.
[2] 姚涛,邹晓毅.PET在癲痫定位诊断中的应用.华西医学,2005,20(2):257-258.
[3] Giovacchini G,Conant S,Herscovitch P,et al.Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.J Nucl Med,2009,50(11):1794-1800.
[4] Benifla M,Sala F Jr,Jane J,et al.Neurosurgical management of intractable rolandic epilepsy in children:role of resection in eloquent cortex.J Neurosurg Pediatr,2009,4(3):199-216.
[5] Richardson EJ,Griffith HR,Martin RC,et al.Structural and functional neuroimaging correlates of depression in temporal lobe epilepsy.Epilepsy Behav,2007,10(2):242-249.
[6] Saeki K,Saito Y,Sugai K,et al.Startle epilepsy associated with gait-induced seizures; Pathomechanism analysis using EEG,MEG,and PET studies.Epilepsia,2009,50(5):1274-1279.
[7] 申广浩,罗二平,路丽华,等.PET、VEEG、MRI癲痫灶定位与病理一致性的研究.中国医学物理学杂志,2008,25(1):481-483.
[8] 李一明,张华,井晓荣,等.比较发作间期PET,M RI和EEG对难治性癲痫的定位价值.第四军医大学学报,2006,27(2):151-154.
[9] Tanriverdi T,Klein D,Mok K,et al.Atypical speech activations:PET results of 92 patients with left-hemispheric epilepsy.Acta Neurochir(Wien),2009,151(10):1175-1190.
[10] Vinton AB,Carne R,Hicks RJ,et al.The extent of resection of FDG-PET hypometabolism relates to outcome of temporal lobectomy.Brain,2007,130(Pt 2):548-560.
[11] Takaya S,Hanakawa T,Hashikawa K,et al.Prefrontal hypopfunction in patients with intractable mesial temporal lobe epilepsy.Neurology,2006,67(9):1674-1676.
[12] Engel J Jr,Kuhi DE,Phelps ME,et al.Interctal cerebral glucose metabolism in patial epilepsy and its relation to EEG changes.Ann Neurol,1982,12(6):510-517.
[13] Joo EY,Hong SB,Han HJ,et al.Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.Brain,2005,128(Pt 8):1802-1810.
[14] Benabid AL,Chabardes S,Torres N,et al.Functional neurosurgery for movement disorders:a historical perspective.Prog Brain Res.2009,175:379-391.
[15] Theodore WH,Giovacchini G,Bonwetsch R,et al.The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography.Epilepsia,2006,47(3):499-503.
[16] Hammers A,Asselin MC,Turkheimer FE,et al.Balancing bias,reliability,noise properties and the need for parametric maps in quantitative ligand PET:[11C]diprenorphine test-retest data.Neuroimage,2007,38(1):82-94.
[17] Padma MV,Simkins R,White P,et al.Clinic alutility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.Neurol India,2004,52(4):457-462.
[18] Bonati MT,Combi R,Asselta R,et al.Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families.J Neurol,2002,249(8):967-974.
[19] Pannell C,Simonian SX,Gillies GE,et al.Hypothalamic somatostatin and growth hormone releasing hormone mRNA expression depend upon GABA(A) receptor expression in the developingmouse.Neuroendocrinology,2002,76(2):93-94.
[20] Duncan JS.Position emission tomography receptor studies.Adv Neuro,1999,79:893-899.
[21] Fowler JS,Volkow ND,Cilento R,et al.Comparison of brain glucose metabolism and monoamine oxidase B(MAO B)in traumatic brain injury.Clin Positron Imaging,1999,2(2):71-79,
[22] Haut SR,Albin RL.Dopamine and epilepsy:hints of complex subcortical roles.Neurology,2008,71(11):784-785.
[23] Mukherjee J,Shi B,Christian BT,et al.11C-Fallypride:radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain.Bioorg Med Chem,2004,12(1):95-102.

相似文献/References:

[1]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
 Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[2]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
 You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[3]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
 Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[4]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
 Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[5]许靖,李肖红,秦永德,等.帕金森病脑部葡萄糖代谢和脑多巴胺转运体PET显像特点的临床研究[J].国际放射医学核医学杂志,2016,40(5):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
 Xu Jing,Li Xiaohong,Qin Yongde,et al.Clinical study of brain glucose metabolism and brain dopamine transporter PET imaging in patients with Parkinson’s disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):338.[doi:10.3760/cma.j.issn.1673-4114.2016.05.003]
[6]曹登敏,林美福,陈文新,等.继发性骨淋巴瘤的18F-FDG PET/CT影像学表现[J].国际放射医学核医学杂志,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
 Cao Dengmin,Lin Meifu,Chen Wenxin,et al.Analysis on 18F-FDG PET/CT imaging characteristics in secondary bone lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):403.[doi:10.3760/cma.j.issn.1673-4114.2016.06.001]
[7]李生栩,唐明灯,林端瑜,等.18F-FDG PET/CT在胸段食管鳞癌淋巴结转移中的诊断价值[J].国际放射医学核医学杂志,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
 Li Shengxu,Tang Mingdeng,Lin Duanyu,et al.Value of 18F-FDG PET/CT in detecting metastatic lymph nodes of thoracic esophageal squamous cell carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):408.[doi:10.3760/cma.j.issn.1673-4114.2016.06.002]
[8]张莹莹,王振光,武凤玉,等.特发性肺间质纤维化HRCT病变区与非病变区18F-FDG PET/CT表现分析[J].国际放射医学核医学杂志,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
 Zhang Yingying,Wang Zhenguang,Wu Fengyu,et al.18F-FDG PET/CT imaging analysis of regions with abnormal and normal pulmonary parenchyma on high resolution CT in idiopathic pulmonary fibrosis patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):414.[doi:10.3760/cma.j.issn.1673-4114.2016.06.003]
[9]张毓艺,姚稚明.18F-FDG PET/CT对非小细胞肺癌淋巴结分期诊断价值的研究进展[J].国际放射医学核医学杂志,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
 Zhang Yuyi,Yao Zhiming.The progress of 18F-FDG PET/CT in the diagnosis of N-staging of non-small cell lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):447.[doi:10.3760/cma.j.issn.1673-4114.2016.06.009]
[10]郝新忠,武志芳,武萍,等.SAPHO综合征18F-FDG PET/CT显像和临床分析[J].国际放射医学核医学杂志,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]
 Hao Xinzhong,Wu Zhifang,Wu Ping,et al.18F-FDG PET/CT imaging and clinical features of SAPHO syndrome[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):447.[doi:10.3760/cma.j.issn.1673-4114.2015.06.003]

备注/Memo

备注/Memo:
收稿日期:2009-05-04。
通讯作者:王雪梅(E-mail:wangxuemei2260@yahoo.com.cn)
更新日期/Last Update: 1900-01-01